Hematology
Conference Coverage
Large cohort study: Bevacizumab safe, effective for severe HHT bleeds
Bevacizumab was effective for severe HHT-related epistaxis and GI bleeds, leading to "significant and striking improvements" on a variety of...
Conference Coverage
SPK-8011 AAV-mediated hemophilia A therapy shows stability, durability
From the Journals
Heavy menstrual bleeding difficult to control in young patients with inherited platelet disorders
Consensus and a broadly effective treatment for heavy menstrual bleeding was not found among the patients with inherited platelet function...
From the Journals
Subcutaneous hep A vaccination as effective as intramuscular for bleeding disorder patients
From the Journals
Biologics may carry melanoma risk for patients with immune-mediated inflammatory diseases
“We advocate for more large, well-designed studies of this issue to be performed to help improve certainty,” the researchers said.
Conference Coverage
Risk index stratifies pediatric leukemia patients undergoing HSCT
From the Journals
Teenage blood donors may need more time, supplements to replenish iron
Young blood donors may be enthusiastic, altruistic, and at increased risk for iron depletion, researchers say.
Latest News
Convalescent plasma: ‘Flavor of the month’ or valid COVID-19 treatment?
“The special attraction of this modality of treatment is that, unlike vaccines or newly developed drugs, it could, in principle, be made available...
Feature
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.
Myth of the Month
Is anemia due to folate deficiency a myth?
This column includes folate test results from several studies.
From the Journals
Inflammation, thrombosis biomarkers tied to COVID-19 deaths
“Of particular interest is the finding that over three quarters of critically ill patients required a ventilator and almost one third required...